These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 10198923)
1. Impact of cholesterol on cardiovascular morbidity and mortality in older adults. Chen YT; Krumholz HM Nutrition; 1999 Mar; 15(3):242-4. PubMed ID: 10198923 [No Abstract] [Full Text] [Related]
2. Cholesterol levels in young adults: screen and intervene? Gotto AM Hosp Pract (Off Ed); 1994 Mar; 29(3):109-10, 115-6. PubMed ID: 8132722 [TBL] [Abstract][Full Text] [Related]
3. Case studies in lipid management. Tallis GA; Popplewell PY; Phillips PJ Aust Fam Physician; 1995 Sep; 24(9):1627-31, 1634-5, 1637. PubMed ID: 7487648 [TBL] [Abstract][Full Text] [Related]
4. Annual influenza immunization: as important as control of blood pressure and cholesterol as secondary prevention for cardiovascular disease. Grajewski J; Slusar M; Hayney MS J Am Pharm Assoc (2003); 2007; 47(5):662-3. PubMed ID: 17848356 [No Abstract] [Full Text] [Related]
5. Management of high blood cholesterol. Smith MD; McGhan WF Bus Health; 1996 Apr; 14(4):67-8, 70, 72-4. PubMed ID: 10157682 [No Abstract] [Full Text] [Related]
6. Cholesterol and the older adult. Kaiser FE South Med J; 1993 Oct; 86(10):2S11-4. PubMed ID: 8211350 [TBL] [Abstract][Full Text] [Related]
7. Lipid-Lowering Therapies: Risks in Women and Evidence-Based Options. Shah T; Virani SS Tex Heart Inst J; 2018 Aug; 45(4):238-239. PubMed ID: 30374235 [No Abstract] [Full Text] [Related]
8. Lipid-lowering therapy and risk of coronary events. Lardinois CK JAMA; 2003 Apr 23-30; 289(16):2071; author reply 2071-2. PubMed ID: 12709463 [No Abstract] [Full Text] [Related]
10. [Cardiovascular prevention: not necessary under the age of 40]. Walma EP Ned Tijdschr Geneeskd; 2009; 153():B351. PubMed ID: 19785804 [TBL] [Abstract][Full Text] [Related]
11. Lipid parameters and cardiovascular events in patients taking statins. Martin SS; Jones SR JAMA; 2012 Jul; 308(2):131-2; author reply 132-3. PubMed ID: 22782402 [No Abstract] [Full Text] [Related]
12. Lipid parameters and cardiovascular events in patients taking statins. Brook RD; Rubenfire M JAMA; 2012 Jul; 308(2):132; author reply 132-3. PubMed ID: 22782403 [No Abstract] [Full Text] [Related]
13. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet; 1994 Nov; 344(8934):1383-9. PubMed ID: 7968073 [TBL] [Abstract][Full Text] [Related]
14. Among statin-treated patients, LDL, non-HDL and apoB cholesterol biomarkers were associated with increased risks of cardiovascular events. Sniderman AD; Thanassoulis G Evid Based Med; 2013 Apr; 18(2):73-4. PubMed ID: 22893654 [No Abstract] [Full Text] [Related]
15. PCSK9 Inhibitors: From Innovation to Sustainable Clinical Application. Lekuona I Rev Esp Cardiol (Engl Ed); 2018 Dec; 71(12):996-998. PubMed ID: 30150140 [No Abstract] [Full Text] [Related]
16. Bridging the treatment gap. Smith SC Am J Cardiol; 2000 Jun; 85(12A):3E-7E. PubMed ID: 10858487 [TBL] [Abstract][Full Text] [Related]
17. High blood cholesterol. National Heart, Lung and Blood Institute Nutr Clin Care; 2003; 6(3):108-14. PubMed ID: 14979453 [TBL] [Abstract][Full Text] [Related]
18. Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. Levine GN; Keaney JF; Vita JA N Engl J Med; 1995 Feb; 332(8):512-21. PubMed ID: 7830734 [No Abstract] [Full Text] [Related]
19. Genetics and molecular biology: rationale for targeting high-density lipoprotein cholesterol for therapeutic intervention. Mukherjee S Curr Opin Lipidol; 2006 Oct; 17(5):602-5. PubMed ID: 16960508 [No Abstract] [Full Text] [Related]
20. [The surprising (?) results of IMPROVE-IT]. Poli A G Ital Cardiol (Rome); 2015 May; 16(5):281-3. PubMed ID: 25994463 [No Abstract] [Full Text] [Related] [Next] [New Search]